New York NY, January 2020 – Intrinsic Therapeutics hosted its first U.S. Disc Collective Meeting on 16-17 January, 2020 in Manhattan, New York. 15 spine surgeons travelled to the East Coast in order to learn more about and exchange experiences on the topic of lumbar disc herniation.
The program was themed around “A future of disc preservation”, and started out on Thursday night with a keynote lecture by Prof. Roger Hartl (Weill Cornell, New York), who reported upon their 10 years of research work in the field of biological treatment strategies for degenerative diseases of the spine, with a specific focus on disc and annulus repair. His lecture was titled “Biologic disc replacement and annulus repair: what does the future hold?”, which led a wonderful introduction to the overall program.
A distinguished invited faculty from Europe, Professor Claudius Thomé (Innsbruck, Austria) and Dr. Ardeshir Ardeshiri (Itzehoe, Germany) presented on lumbar disc disease and surgery in general, as well as their extensive clinical experience with the Barricaid annular closure device, referencing over 40 peer-reviewed publications that have summarized their clinical results and that of others.
“No hype, but it was one of the best meetings of its kind that I have ever attended. The information that was presented, the interactions, and the level of expertise that were there were fantastic.” – Neurosurgeon from Washington State
The founding members of the U.S. Disc Collective Group all agreed to the need to turn more attention to lumbar disc herniation treatment, a topic that many believe is mundane and already fully understood. New and proven technologies as Barricaid Annular Closure give surgeons a chance to provide their lumbar discectomy patients with more durable outcomes.
Intrinsic Therapeutics is committed to supporting the Disc Collective initiative with an annual meeting that will provide the attendees with a state-of-art update on the topic of disc disease and surgery, as well as a platform to discussing the advancement of innovative, evidence-based lumbar disc therapies.